Deprescribing Trials: Methods to Reduce Polypharmacy and the Impact on Prescribing and Clinical Outcomes - 13/04/12
Doi : 10.1016/j.cger.2012.01.006
Danijela Gnjidic, PhD, MPH a, b, c, ⁎ 
, David G. Le Couteur, MBBS, PhD b, c, d, Lisa Kouladjian, BMedSc (Hons), MPharm a, Sarah N. Hilmer, MBBS, PhD a, b
, David G. Le Couteur, MBBS, PhD b, c, d, Lisa Kouladjian, BMedSc (Hons), MPharm a, Sarah N. Hilmer, MBBS, PhD a, b a Departments of Clinical Pharmacology and Aged Care, 11C Main Building, Royal North Shore Hospital, St Leonards NSW 2065, Australia
b Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia
c Centre for Education and Research on Ageing, Concord Hospital, C22, Concord NSW 2139, Australia
d ANZAC Medical Research Institute, Concord Hospital and University of Sydney, Concord NSW 2139, Australia
Corresponding author. Sydney Medical School, University of Sydney, Sydney, NSW 2006, AustraliaKeywords : Effectiveness of interventions, Medications, Polypharmacy, Medication withdrawal, Older adults
Plan
| Disclosures: The authors gratefully acknowledge the funding support from the Geoff and Elaine Penney Ageing Research Unit and the Ageing and Alzheimer's Research Foundation. |
Crown Copyright © 2012
Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 28 - N° 2
P. 237-253 - mai 2012 Retour au numéro
Article précédent
- Outcomes of Polypharmacy in Nursing Home Residents
- Bruce K. Tamura, Christina L. Bell, Michiko Inaba, Kamal H. Masaki
- Ethical Framework for Medication Discontinuation in Nursing Home Residents with Limited Life Expectancy
- Jennifer Tjia, Jane Givens
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?